title: Exemestane or tamoxifen?
authors.forename: Gianluigi
authors.initials: G
authors.lastname: Ferretti
authors.forename: Alessandra
authors.initials: A
authors.lastname: Felici
authors.forename: Paolo
authors.initials: P
authors.lastname: Carlini
authors.forename: Francesco
authors.initials: F
authors.lastname: Cognetti
mesh_terms: D000730:Androstadienes / Q000009:adverse effects / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control*; D005500:Follow-Up Studies; D006801:Humans; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D000730:Androstadienes; D047072:Aromatase Inhibitors; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; C056516:exemestane